Elevance Health (ELV) Fair Value & DCF
Score
ELV fair value $726.59. Price $429.69. Price is 41% below fair value.
Worked example
Cash-flow value. Starting free cash flow is $30.15 a share. Year 1 is the first earnings forecast, so it has no growth rate of its own. The forecast then reaches 15.23%, and that pace fades in a straight line to 3% terminal growth by year 10. The discount rate is 8.70% (beta 0.80). It is beta-adjusted and capped at 12%. The cash-flow value is $765.59 a share.
Earnings value. Next-twelve-months earnings per share of $28.82 times 23.86 is $687.58. The peer group is Healthcare, 74 companies worth at least $10 billion. Peer median 30.9. Own 10-year median 16.8. The multiple used is the average of the two, kept between 8 and 30, which is 23.86.
Fair value is the average of the two, $726.59. The price is $429.69, which is 40.9% below fair value.